Keurig Dr Pepper Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $847.0m
$1.1b +27.04%
$586.0m -45.54%
$1.3b +113.99%
$1.3b +5.66%
$2.1b +61.96%
$1.4b -33.08%
$2.2b +51.88%
$1.4b -33.93%
$2.1b +44.27%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $589.0m $1.3b $1.3b $2.1b $1.4b $2.2b $1.4b
Net Income (Loss) Attributable to Noncontrolling Interest $3.0m $0 $0 ($1.0m) ($1.0m) $0 $0
Depreciation and amortization $99.0m $102.0m $970.0m
Amortization $33.0m $31.0m $410.0m
Amortization of Intangible Assets $3.0m $7.0m $121.0m $126.0m $133.0m $134.0m $138.0m $137.0m $133.0m $138.0m
Depreciation $191.0m $198.0m $233.0m $358.0m $362.0m $410.0m $399.0m $402.0m $422.0m $455.0m $560.0m
Deferred Income Tax Expense (Benefit) $29.0m ($201.0m) ($81.0m) ($23.0m) ($51.0m) $31.0m ($289.0m) ($4.0m) ($254.0m) $45.0m $19.0m
Share-based Payment Arrangement, Noncash Expense $45.0m $36.0m $35.0m $64.0m $85.0m $88.0m $52.0m $116.0m $98.0m $97.0m $114.0m
Payment, Tax Withholding, Share-based Payment Arrangement $31.0m $30.0m $125.0m $15.0m $62.0m $61.0m $31.0m
Share-based Payment Arrangement, Expense $45.0m $36.0m $35.0m $64.0m $85.0m $88.0m $52.0m $116.0m $98.0m $97.0m $114.0m
Equity Method Investment, Other than Temporary Impairment $102.0m $17.0m $12.0m $0 $2.0m
Goodwill and Intangible Asset Impairment $0 $0 $67.0m $0 $477.0m $2.0m $412.0m $78.0m
Goodwill, Impairment Loss $0 $0 $306.0m $0 $78.0m
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $67.0m $0 $477.0m $2.0m $412.0m $78.0m
Impairment of Intangible Assets, Finite-lived $0 $0 $0 $5.0m $2.0m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $1.0m $0 $0 $67.0m $0 $472.0m $2.0m $412.0m $78.0m
Equity Method Investment, Realized Gain (Loss) on Disposal $524.0m $50.0m $0 $0
Income (Loss) from Equity Method Investments ($2.0m) ($2.0m) $17.0m ($51.0m) ($20.0m) ($5.0m) ($5.0m) $33.0m $42.0m $81.0m
Other Nonoperating Income (Expense) $25.0m $8.0m $19.0m ($19.0m) ($17.0m) $2.0m ($14.0m) $61.0m $60.0m ($134.0m)
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $31.0m $47.0m ($82.0m) $7.0m $5.0m $152.0m $398.0m ($70.0m) $209.0m $202.0m ($155.0m)
Accounts Receivable, Credit Loss Expense (Reversal) $5.0m $2.0m ($13.0m) $3.0m $3.0m $0 ($155.0m)
Increase (Decrease) in Inventories ($3.0m) $0 ($185.0m) $24.0m $107.0m $133.0m $426.0m ($182.0m) $92.0m $405.0m $144.0m
Other Operating Income (Expense), Net $3.0m $51.0m ($10.0m) ($2.0m) $39.0m $70.0m $105.0m $26.0m ($207.0m) $5.0m
Net Cash Provided by (Used in) Operating Activities $939.0m
$1.0b +10.54%
$1.6b +55.39%
$2.5b +53.38%
$2.5b -0.73%
$2.9b +17.02%
$2.8b -1.29%
$1.3b -53.15%
$2.2b +66.97%
$2.0b -10.27%
$2.5b +26.92%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment $6.0m $3.0m $5.0m ($14.0m) $36.0m $75.0m $80.0m $1.0m ($16.0m) $2.0m ($202.0m)
Payments to Acquire Property, Plant, and Equipment $180.0m $202.0m $180.0m $330.0m $461.0m $423.0m $353.0m $425.0m $563.0m $486.0m ($562.0m)
Unrealized Gain (Loss) on Investments $28.0m ($24.0m) ($1.0m) $5.0m $4.0m $16.0m $33.0m ($6.0m)
Payments to Acquire Businesses, Net of Cash Acquired $1.0b $149.0m ($16.7b)
Payments for (Proceeds from) Other Investing Activities $8.0m $3.0m ($6.0m) ($24.0m) ($9.0m) $16.0m ($6.0m) ($4.0m) ($11.0m) ($66.0m)
Net Cash Provided by (Used in) Investing Activities ($189.0m) ($1.8b) ($19.1b) ($150.0m) ($316.0m) $210.0m ($1.1b) ($784.0m) ($1.6b) ($573.0m) ($17.2b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($31.0m) ($62.0m) ($13.0m) ($11.0m) ($4.0m) ($105.0m) ($217.0m) $0 $0
Payments for Repurchase of Common Stock $519.0m $399.0m $379.0m $706.0m $1.1b $9.0m
Payments of Ordinary Dividends, Common Stock $386.0m $414.0m $232.0m $844.0m $846.0m $955.0m $1.1b $1.1b $1.2b $1.2b ($1.3b)
Proceeds from Issuance of Common Stock $9.0b $0 $0 $140.0m $0 $0
Payments of Dividends $386.0m $414.0m $232.0m $844.0m $846.0m $955.0m $1.1b $1.1b $1.2b $1.2b ($1.3b)
Dividends Payable, Current $97.0m $209.0m $212.0m $212.0m $265.0m $281.0m $299.0m $312.0m
Dividends Payable $97.0m $103.0m $211.0m $211.0m $212.0m $265.0m $281.0m $299.0m $312.0m $312.0m
Proceeds from (Payments for) Other Financing Activities ($1.0m) $0 $4.0m $5.0m $0 ($36.0m) ($46.0m) ($6.0m) ($23.0m) ($5.0m)
Net Cash Provided by (Used in) Financing Activities $130.0m
($907.0m) -797.69%
$17.6b +2037.93%
($2.4b) -113.45%
($2.0b) +15.82%
($2.8b) -38.79%
($1.7b) +37.44%
($832.0m) +51.85%
($223.0m) +73.20%
($999.0m) -347.98%
$16.0b +1697.20%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $158.0m $139.0m $111.0m $255.0m $568.0m $535.0m $267.0m $608.0m $1.0b $1.9b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($97.0m) ($15.0m) $12.0m ($6.0m) ($9.0m) ($7.0m) $19.0m ($41.0m) $17.0m ($301.0m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $14.0m $20.0m $0
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $180.0m $521.0m $515.0m $477.0m $363.0m $443.0m $494.0m $594.0m
Additional Financial Items
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement $2.0m ($1.0m)
Foreign Currency Transaction Gain (Loss), Unrealized $28.0m ($24.0m) $1.0m ($9.0m) ($26.0m) $13.0m ($33.0m) $6.0m
Gain (Loss) Related to Litigation Settlement $299.0m $0 $0
Goodwill $3.0b $3.6b $20.0b $20.2b $20.2b $20.2b $20.1b $20.2b $20.1b $20.2b $78.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $849.0m $1.1b
Income Tax Expense (Benefit) $434.0m $95.0m $202.0m $440.0m $428.0m $653.0m $284.0m $576.0m $473.0m $608.0m
Investment Income, Interest $3.0m $3.0m
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($6.0m) ($13.0m)
Payments of Financing Costs $19.0m $5.0m $55.0m $0
Proceeds from Contributions from Affiliates $0 $0
Proceeds from (Payments to) Noncontrolling Interests $18.0m $0 $0
Provision for Loan, Lease, and Other Losses $17.0m
Unrealized Gain (Loss) on Derivatives $4.0m ($49.0m) ($36.0m) ($8.0m) $70.0m ($383.0m) ($31.0m) ($91.0m) $1.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.